Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$272M |
| 2 |
Chevron
CVX
|
+$206M |
| 3 |
Tesla
TSLA
|
+$153M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Pfizer
PFE
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
First Solar
FSLR
|
+$153M |
| 3 |
Walmart Inc
WMT
|
+$133M |
| 4 |
Steel Dynamics
STLD
|
+$115M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.92% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.68% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Design Therapeutics
DSGN
$788M
| $375K | ﹤0.01% |
59,635
-16,850
| -22% | -$103K |
|
|
SAND
3127
DELISTED
Sandstorm Gold
SAND
| $368K | ﹤0.01% |
71,825
-15,928
| -18% | -$88.7K |
|
3128
United Bancorp
UBCP
$89.8M
| $368K | ﹤0.01% |
30,801
| – | – |
|
3129
NetSol Technologies
NTWK
$50.8M
| $365K | ﹤0.01% |
154,862
-59,516
| -28% | -$140K |
|
3130
Annovis Bio
ANVS
$75.3M
| $361K | ﹤0.01% |
25,251
| – | – |
|
|
SPPI
3131
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $357K | ﹤0.01% |
371,752
-40
| -0% | -$40 |
|
|
PTRA
3132
DELISTED
Proterra Inc. Common Stock
PTRA
| $353K | ﹤0.01% |
294,105
-255,868
| -47% | -$314K |
|
|
OKUR
3133
OnKure Therapeutics
OKUR
$162M
| $351K | ﹤0.01% |
5,353
+1,651
| +45% | +$133K |
|
|
MRNS
3134
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $348K | ﹤0.01% |
32,089
| – | – |
|
|
OGI
3135
Organigram Holdings
OGI
$136M
| $347K | ﹤0.01% |
222,631
-26,433
| -11% | -$51K |
|
3136
Atea Pharmaceuticals
AVIR
$379M
| $345K | ﹤0.01% |
92,351
+30,712
| +50% | +$115K |
|
|
ENFN
3137
DELISTED
Enfusion, Inc.
ENFN
| $340K | ﹤0.01% |
+30,291
| New | +$269K |
|
3138
Bank First Corp
BFC
$1.68B
| $339K | ﹤0.01% |
4,079
| – | – |
|
3139
Pixelworks
PXLW
$37.4M
| $337K | ﹤0.01% |
16,226
-16,174
| -50% | -$312K |
|
|
CAMP
3140
DELISTED
CalAmp Corp.
CAMP
| $336K | ﹤0.01% |
13,784
-4,945
| -26% | -$240K |
|
3141
CF Bankshares
CFBK
$235M
| $333K | ﹤0.01% |
21,939
+846
| +4% | +$14K |
|
3142
Acumen Pharmaceuticals
ABOS
$157M
| $332K | ﹤0.01% |
68,979
+2,200
| +3% | +$10.5K |
|
3143
Paysign
PAYS
$512M
| $330K | ﹤0.01% |
134,849
+89,461
| +197% | +$275K |
|
3144
ImmuCell
ICCC
$100M
| $328K | ﹤0.01% |
64,264
-425
| -0.7% | -$2.17K |
|
3145
Solid Biosciences
SLDB
$836M
| $326K | ﹤0.01% |
62,164
+5,829
| +10% | +$32.8K |
|
|
SSBK
3146
DELISTED
Southern States Bancshares
SSBK
| $325K | ﹤0.01% |
15,383
+4,915
| +47% | +$106K |
|
3147
Workiva
WK
$3.29B
| $318K | ﹤0.01% |
+3,128
| New | +$301K |
|
3148
Telos
TLS
$324M
| $318K | ﹤0.01% |
124,040
-152,841
| -55% | -$362K |
|
|
FORTY
3149
Formula Systems
FORTY
$1.63B
| $316K | ﹤0.01% |
4,303
| – | – |
|
3150
NextCure
NXTC
$20.5M
| $315K | ﹤0.01% |
14,578
-2,524
| -15% | -$49.7K |
|
Similar funds
Dimensional Fund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
- Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
- Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
- Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
- Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.